| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc. | Director, 10%+ Owner | Common Stock | 4.03M | $22.3M | $5.53 | 11 Jan 2024 | Indirect |
| Foghorn Therapeutics Inc. | Director | Stock Options (Right to buy) | 16K | $88.3K | $5.52 | 26 Jun 2024 | Direct |
| Cerevel Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $41.18 | 01 Aug 2024 | Direct |
| Cerevel Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $41.18 | 01 Aug 2024 | Indirect |
| Aptinyx Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 40K | 26 May 2022 | Direct | ||
| Solid Biosciences Inc. | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 9.65K | 06 Jun 2023 | Direct | ||
| Cerevel Therapeutics Holdings, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 0 | 01 Aug 2024 | Direct | ||
| Dicerna Pharmaceuticals Inc | Director | Common Stock | 0 | $38.25 | 28 Dec 2021 | Direct | |
| Dicerna Pharmaceuticals Inc | Director | Common Stock | 0 | $38.25 | 28 Dec 2021 | Indirect | |
| Dicerna Pharmaceuticals Inc | Director | Director Stock Option (Right to Buy) | 0 | 28 Dec 2021 | Direct | ||
| Dicerna Pharmaceuticals Inc | Director | Restricted Stock Units | 0 | 28 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | 29 Dec 2024 | 0 | $0 | 4 | Director | 30 Dec 2024, 07:54 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 01 Aug 2024 | 4 | $0 | 4 | Director, 10%+ Owner | 05 Aug 2024, 16:49 |
| FHTX | Foghorn Therapeutics Inc. | 26 Jun 2024 | 1 | $88.3K | 4 | Director | 28 Jun 2024, 16:00 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 07 Jun 2024, 17:12 |
| SLDB | Solid Biosciences Inc. | 11 Jan 2024 | 1 | $5M | 4 | Director, 10%+ Owner | 12 Jan 2024, 16:56 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 16 Oct 2023 | 1 | $125M | 4 | Director, 10%+ Owner | 18 Oct 2023, 16:30 |
| FHTX | Foghorn Therapeutics Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 22 Jun 2023, 20:12 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 07 Jun 2023 | 3 | $0 | 4 | Director, 10%+ Owner | 09 Jun 2023, 17:07 |
| SLDB | Solid Biosciences Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 08 Jun 2023, 17:01 |
| SLDB | Solid Biosciences Inc. | 13 Dec 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 15 Dec 2022, 17:19 |
| SLDB | Solid Biosciences Inc. | 02 Dec 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 05 Dec 2022, 16:16 |
| SLDB | Solid Biosciences Inc. | 02 Dec 2022 | 0 | $0 | 3 | Director, 10%+ Owner | 05 Dec 2022, 15:58 |
| FHTX | Foghorn Therapeutics Inc. | 21 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 20:59 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 16 Jun 2022, 17:10 |
| APTX | Aptinyx Inc. | 26 May 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 31 May 2022, 17:06 |
| DRNA | Dicerna Pharmaceuticals Inc | 28 Dec 2021 | 9 | -$118M | 4 | Director | 29 Dec 2021, 15:43 |
| FHTX | Foghorn Therapeutics Inc. | 13 Jul 2021 | 1 | $0 | 4 | Director | 14 Jul 2021, 16:53 |
| SLDB | Solid Biosciences Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 17:15 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 14 Jun 2021, 20:25 |
| DRNA | Dicerna Pharmaceuticals Inc | 03 Jun 2021 | 4 | $0 | 4 | Director | 07 Jun 2021, 18:50 |
| APTX | Aptinyx Inc. | 27 May 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 01 Jun 2021, 16:30 |